FindMyRecallSubscribe
Class I: serious health riskOngoing

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals Spironolactone Tablets Recall

Spironolactone Tablets, USP, 25 mg, packaged in: a) 30-count bottles (NDC 63629-1064-01…

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals · Burbank, CA

Risk level
Class I
Reported by FDA
Mar 24, 2021
Recall ID
D-0303-2021
Check your lot numberHow we source this data

Summary

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals recalled Spironolactone Tablets starting Jan 27, 2021. The FDA classified it as Class I (serious health risk) and published enforcement report D-0303-2021 on Mar 24, 2021. Reason: Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets. Status: Ongoing.

Why it was recalled

Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets.

Product description

Spironolactone Tablets, USP, 25 mg, packaged in: a) 30-count bottles (NDC 63629-1064-01), b) 60-count bottles (NDC 63629-1064-02), c) 90-count bottles (NDC 63629-1064-03), Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA

Lot numbers, UPCs & expiration codes

a) Lot #: 148969, Exp 7/31/2022, b) Lot #: 148791, Exp 7/31/2022, c) Lot #: 148991, Exp 7/31/2022

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0303-2021
Classification
Class I
Status
Ongoing
Recall initiated
Jan 27, 2021
FDA report date
Mar 24, 2021
Quantity
35 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-0303-2021, exactly as published.

Show all FDA fields
City
Burbank
State
CA
Status
Ongoing
Country
United States
Event ID
87283
Address
1919 N Victory Pl
Code information
a) Lot #: 148969, Exp 7/31/2022, b) Lot #: 148791, Exp 7/31/2022, c) Lot #: 148991, Exp 7/31/2022
Postal code
91504-3425
Report date
Mar 24, 2021
Product type
Drugs
Recall number
D-0303-2021
Classification
Class I
Recalling firm
Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals
Product quantity
35 bottles
Reason for recall
Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Spironolactone Tablets, USP, 25 mg, packaged in: a) 30-count bottles (NDC 63629-1064-01), b) 60-count bottles (NDC 63629-1064-02), c) 90-count bottles (NDC 63629-1064-03), Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA
Distribution pattern
Nationwide in the USA
Recall initiation date
Jan 27, 2021
Initial firm notification
E-Mail
Center classification date
Mar 16, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0303-2021, published Mar 24, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls